title: Drug-resistant tuberculosis in the Philippines.
authors.forename: A B
authors.initials: AB
authors.lastname: Rivera
authors.forename: T E
authors.initials: TE
authors.lastname: Tupasi
authors.forename: E D
authors.initials: ED
authors.lastname: Balagtas
authors.forename: R C
authors.initials: RC
authors.lastname: Cardano
authors.forename: B Q
authors.initials: BQ
authors.lastname: Baello
authors.forename: I D
authors.initials: ID
authors.lastname: Quelapio
authors.forename: L A
authors.initials: LA
authors.lastname: Villa
authors.forename: L G
authors.initials: LG
authors.lastname: Pascual
authors.forename: V M
authors.initials: VM
authors.lastname: Co
authors.forename: M J
authors.initials: MJ
authors.lastname: Mantala
mesh_terms: D000995:Antitubercular Agents / Q000494:pharmacology* / Q000627:therapeutic use; D018432:Drug Resistance, Multiple; D004977:Ethambutol / Q000008:administration & dosage; D005260:Female; D006801:Humans; D015994:Incidence; D007538:Isoniazid / Q000008:administration & dosage; D008297:Male; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D010679:Philippines / Q000453:epidemiology; D011718:Pyrazinamide / Q000008:administration & dosage; D012293:Rifampin / Q000008:administration & dosage; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis / Q000453:epidemiology*
chemical_list: D000995:Antitubercular Agents; D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin